🟢 Abivax is trading 4.02% up today as XBI gains 2.75%

Abivax is trading 4.02% up now at $115.54, with the move primarily supported by biotechnology-sector strength.

• XBI is up 2.75%, alongside a broadly positive U.S. market.
• No clear company-specific announcement was identified for September 3, 2026.
• A September 3 STAT article discussed ongoing acquisition speculation but provided no transaction announcement or direct trading catalyst.